NASDAQ:CRGX - Nasdaq - US14179K1016 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 172.19M | 96.71M | 34.77M | 5.98M | |||
Research and Development | 130.96M | 75.79M | 29.37M | 4.46M | |||
Selling, General, and Administrative Expenses | 41.23M | 20.92M | 5.40M | 1.52M | |||
Operating Income | -172.19M | -96.71M | -34.77M | -5.98M | |||
Interest Income/Expense | 15.39M | 4.85M | -6.16M | 0.00 | |||
Other Income/Expense | 2.65M | -3.97M | -20.00K | 130.00K | |||
Non Recurring Items | N/A | -2.32M | N/A | N/A | |||
Income Before Taxes | -154.14M | -98.15M | -40.95M | -5.85M | |||
Net Income | -154.14M | -98.15M | -40.95M | -5.85M | |||
EBITDA | -169.78M | -95.22M | -34.37M | -5.96M | |||
Per Share Data | |||||||
EPS Diluted Total Ops | -3.43 | -2.38 | -1.06 | -0.15 | |||
Non GAAP EPS | -4.26 | N/A | N/A | N/A | |||
Statistics |
All data in USD